Back to 
BARCLAYS PLCENENGN
BARCLAYS PLCENENGN1 quarters
Position history for BARCLAYS PLC's holdings in ENGENE THERAPEUTICS INC COM
Yes. Barclays holds 282,515 shares of ENGN (Engene Therapeutics), worth $488,751, as of its Q2 2026 13F filing.
Current Value
$488,751
Current Shares
282,515
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ENGN: AMERIPRISE FINANCIAL INC, MARSHALL WACE, LLP, BALYASNY ASSET MANAGEMENT L.P., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC